Medtronic (MDT) Stock Analysis
Medtronic trades on the NYSE under the ticker MDT. StonkBuddy files it under Healthcare. It is in the S&P 500.
MDT price context
- 52-week range: $73.31 to $106.33 (as of October 23, 2026)
- Market value: about $118.67 billion (October 20, 2026)
Congress trades in MDT
In the last 12 months, members of Congress reported 8 trades in MDT (House and Senate disclosure reports). The latest reported:
- Kevin Hern: Sold, $15,001 - $50,000, traded August 24, 2026, reported September 1, 2026 (filing)
- Richard McCormick: Sold, $1,001 - $15,000, traded July 30, 2026, reported August 14, 2026 (filing)
- Gilbert Ray Cisneros, Jr.: Sold part, $1,001 - $15,000, traded May 15, 2026, reported June 8, 2026 (filing)
- Alan Armstrong: Bought, $1,001 - $15,000, traded March 27, 2026, reported July 21, 2026 (filing)
- Kevin Hern: Sold, $15,001 - $50,000, traded March 20, 2026, reported April 3, 2026 (filing)
All Congress trades · Filed this week
Insider trades in MDT
Since September 30, 2026, Medtronic's officers, directors and large owners have filed 2 open-market buys and sales of its shares (SEC Form 4). The latest reported:
- Geoffrey Martha, Chairman and CEO, sold 50,000 shares at $95.00 on October 15, 2026, reported October 16, 2026 (Form 4)
- Michael Marinaro, EVP, Pres MedSurg and Americas, sold 10,420 shares at $96.00 on October 15, 2026, reported October 16, 2026 (Form 4)
Members also see the StonkBuddy score for MDT on this page. What the score means